SubsidieMeestersA life-changing PREssure Sensor System for UROdynamics to solve global urinary storage and voiding problems
PRESSURO is a groundbreaking bladder pressure sensor system that enables continuous, natural measurement for improved diagnosis and treatment of urinary dysfunction in millions of patients.
Projectdetails
Introduction
900 million patients globally suffer from urinary dysfunction. Setting the right diagnosis and deciding upon the right treatment (medication, assistive devices, rehabilitation, and/or surgery) can sometimes be very challenging.
Current Technology Limitations
Today's technology provides a limited 15-minute snapshot based on the artificial filling of the bladder. There is a clear need for a technology that can provide high resolution, accurate, and realistic bladder pressure data over time based on natural filling.
PRESSURO Technology
PRESSURO is a revolutionary micro and nanotechnology pressure sensor system based on more than 10 years of research at SINTEF.
Key Features
- The sensor will be inserted directly into the bladder.
- It enables continuous measurement based on natural physiology for up to 30 days.
Impact on Patient Care
This solution will provide a completely new understanding of bladder function and enable better diagnosis and treatment for millions of patients.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.000 |
| Totale projectbegroting | € 6.787.550 |
Tijdlijn
| Startdatum | 1-11-2022 |
| Einddatum | 31-10-2024 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- INVIVO BIONICS ASpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Multianalyte Continuum Nanopores SensingMC-Nano aims to develop a real-time nanopore sensing tool for continuous monitoring of heart failure biomarkers in urine, enhancing diagnostic accuracy and personalizing patient treatment. | ERC POC | € 150.000 | 2024 | Details |
WEARABLE ULTRASOUND FOR CONTINUOUS BLADDER MONITORINGBladderWatch aims to transform LUTD management with a wireless, wearable ultrasonic device for continuous bladder volume monitoring, enhancing patient outcomes and reducing healthcare costs. | ERC POC | € 150.000 | 2024 | Details |
Geautomatiseerde bloeddrukmetingHet project onderzoekt de haalbaarheid van continue bloeddrukmeting met innovatieve micro-wearables om hypertensie beter te diagnosticeren en zorgkosten te verlagen. | MIT Haalbaarheid | € 20.000 | 2022 | Details |
Pressure Sensor MedRingLiGalli onderzoekt de haalbaarheid van een diagnostische Pressure Sensor MedRing voor vrouwen na bekkenbodemoperatie, om herstel te verbeteren en zorgbelasting te verlagen. | MIT Haalbaarheid | € 20.000 | 2020 | Details |
Multianalyte Continuum Nanopores Sensing
MC-Nano aims to develop a real-time nanopore sensing tool for continuous monitoring of heart failure biomarkers in urine, enhancing diagnostic accuracy and personalizing patient treatment.
WEARABLE ULTRASOUND FOR CONTINUOUS BLADDER MONITORING
BladderWatch aims to transform LUTD management with a wireless, wearable ultrasonic device for continuous bladder volume monitoring, enhancing patient outcomes and reducing healthcare costs.
Geautomatiseerde bloeddrukmeting
Het project onderzoekt de haalbaarheid van continue bloeddrukmeting met innovatieve micro-wearables om hypertensie beter te diagnosticeren en zorgkosten te verlagen.
Pressure Sensor MedRing
LiGalli onderzoekt de haalbaarheid van een diagnostische Pressure Sensor MedRing voor vrouwen na bekkenbodemoperatie, om herstel te verbeteren en zorgbelasting te verlagen.